Veracyte (VCYT) Financial Statements & Analysis

Veracyte (VCYT) Income Statement

Veracyte reported revenue of $517.14M in fiscal 2025 (fiscal year ended Dec 31, 2025), up 16.0% from $445.76M a year earlier. Net income was $66.35M, up 174.9% year over year, a net margin of 12.8%. Gross margin was 70.1% and operating margin 11.2%. In the most recent quarter, Q2 fiscal 2026 (ended Jun 30, 2026), revenue was $150.32M, up 15.5% from the same quarter a year earlier.

Veracyte Income Statement Analysis

Values in millions USD

Income Statement Balance Sheet Cash Flow Ratios

Scale:

Scroll to see more

Veracyte, Inc. income statement - Annual data in millions USD
Breakdown	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017
Period ending	Dec 2025	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020	Dec 2019	Dec 2018	Dec 2017
Revenue & Gross Profit
Revenue	517.15	445.76	361.05	296.54	219.51	117.48	120.37	92.01	71.95
Cost of Revenue	143.95	136.07	112.90	101.58	74.40	40.37	36.52	33.08	28.20
Gross Profit	362.53	298.15	248.15	175.68	145.11	77.12	83.85	58.93	43.76
Operating Expenses
Research & Development	70.81	69.29	57.31	40.60	29.84	17.20	14.85	14.82	13.88
Selling, General & Administrative	226.24	203.88	184.23	170.61	181.19	87.61	82.72	65.28	55.35
Operating Expenses	304.76	282.00	333.94	216.76	225.48	109.91	98.97	81.16	70.30
Operating Income	57.78	16.14	-85.80	-41.08	-80.37	-32.80	-15.13	-22.23	-26.54
Other Income/Expense
Interest Income	12.72	11.15	7.34	1.97	0.14	0.59	3.03	0.00	0.00
Interest Expense	0.00	0.00	0.02	-0.20	0.24	-0.23	0.68	1.96	4.94
Other Income/Expense	10.42	9.60	9.18	4.65	-1.18	0.06	2.53	-0.77	-4.47
Income
Income Before Tax	68.20	25.74	-76.61	-36.43	-81.65	-34.91	-12.60	-23.00	-31.00
Income Tax Expense	1.85	1.61	-2.21	0.13	-6.09	0.00	0.00	0.00	0.00
Net Income	66.35	24.14	-74.40	-36.56	-75.56	-34.91	-12.60	-23.00	-31.00
Net Income - Continuous Operations	66.35	24.14	-74.40	-36.56	-75.56	-34.91	-12.60	-23.00	-31.00
Net Income - Discontinued Operations	-	-	-	-	-	-	-	-	-
EBITDA	84.40	45.14	-49.41	-11.68	-61.82	-24.85	-7.81	-17.12	-23.76
EBIT	62.99	21.68	-76.60	-37.61	-81.41	-32.80	-	-	-
Depreciation & Amortization	2.49	23.46	27.19	25.93	15.98	7.94	4.12	3.92	3.84
Earnings Per Share
Basic EPS	1.00	-	-1.00	-1.00	-1.00	-1.00	-	-1.00	-1.00
Diluted EPS	1.00	-	-1.00	-1.00	-1.00	-1.00	-	-1.00	-1.00
Basic Shares Outstanding	78.58	76.48	72.64	71.55	67.89	53.24	46.14	37.02	33.93
Diluted Shares Outstanding	80.57	78.16	72.64	71.55	67.89	53.24	46.14	37.02	33.93

Source: Company financial statements from annual and quarterly filings. Data as of Jun 30, 2026. Data sources and methodology

Frequently Asked Questions About Veracyte Financial Statements

What was Veracyte's revenue in fiscal 2025?

Veracyte reported revenue of $517.14M in fiscal 2025 (fiscal year ended Dec 31, 2025). That was up 16.0% from $445.76M a year earlier.

Is Veracyte profitable?

Yes. Veracyte earned net income of $66.35M in fiscal 2025, a net margin of 12.8%. In fiscal 2024 it earned $24.14M.

What is Veracyte's operating margin?

Veracyte's operating income was $57.78M on revenue of $517.14M in fiscal 2025, an operating margin of 11.2%, compared with 3.6% a year earlier.

What is net profit margin?

Net profit margin is net income divided by revenue. It shows how much of each dollar of sales a company keeps as profit after all costs, interest and taxes. Full definition